Chronic thromboembolic pulmonary hypertension

E-poster session
Chairs: G. Simonneau (Le Kremlin-Bicêtre, France), L. Godinas (Leuven, Belgium)

The assessment of lung function and residual hypoxemia after balloon pulmonary angioplasty for patients with non-operable chronic thromboembolic hypertension Y. Matsuoka (KobeKobe Hyogo, Japan), Y. Taniguchi (Kobe Hyogo, Japan), K. Miwa (Kobe Hyogo, Japan), K. Sumimoto (Kobe Hyogo, Japan), H. Onishi (Kobe Hyogo, Japan), Y. Tsuboi (Kobe Hyogo, Japan), N. Emoto (Kobe Hyogo, Japan), K. Hirata (Kobe Hyogo, Japan)
Initial dual oral combination therapy prior to pulmonary endarterectomy (PEA) in patients with operable chronic thromboembolic pulmonary hypertension (CTEPH) and high preoperative pulmonary vascular resistance (PVR) Y. Trigui (Marseille, France), G. Acquati (Le Kremlin-Bicêtre, France), M. Jevnikar (Le Kremlin-Bicêtre, France), D. Montani (Le Kremlin-Bicêtre, France), L. Savale (Le Kremlin-Bicêtre, France), O. Sitbon (Le Kremlin-Bicêtre, France), O. Mercier (Le Plessis Robinson, France), F. Parent (Le Kremlin-Bicêtre, France), E. Jutant (Le Kremlin-Bicêtre, France), M. Reynaud-Gaubert (Marseille, France), E. Fadel (Le Plessis Robinson, France), G. Simonneau (Le Kremlin-Bicêtre, France), M. Humbert (Le Kremlin-Bicêtre, France), X. Jais (Le Kremlin-Bicêtre, France)
Accuracy of pre-operative specimen level prediction in chronic thromboembolic pulmonary hypertension (CTEPH) patients undergoing pulmonary thromboendarterectomy (PTE) P. Pirompanich (Pathumthani, Thailand), T. Fernandes (California, United States of America), K. Kerr (California, United States of America), M. Madani (California, United States of America), D. Papamatheakis (California, United States of America), D. Poch (California, United States of America), V. Pretorius (California, United States of America), N. Kim (California, United States of America)
Sequential multimodal therapy in patients with chronic thromboembolic pulmonary hypertension (CTEPH) M. Jevnikar (Le Kremlin-Bicêtre, France), S. Solinas (Le Kremlin-Bicêtre, France), P. Brenot (Le Plessis Robinson, France), D. Montani (Le Kremlin-Bicêtre, France), L. Savale (Le Kremlin-Bicêtre, France), O. Sitbon (Le Kremlin-Bicêtre, France), E. Fadel (Le Plessis Robinson, France), G. Simonneau (Le Kremlin-Bicêtre, France), M. Humbert (Le Kremlin-Bicêtre, France), X. Jais (Le Kremlin-Bicêtre, France)
Serial cardiac MRI for assessment of cardiac morphology and function in CTEPH patients after PEA or vasodilator therapy D. Alkhanfar (Sheffield, United Kingdom), Y. Shahin (Sheffield, United Kingdom), F. Alandejani (Sheffield, United Kingdom), S. Alabed (Sheffield, United Kingdom), C. Johns (Sheffield, United Kingdom), A. Mk Rothman (Sheffield, United Kingdom), P. Garg (Sheffield, United Kingdom), R. Condliffe (Sheffield, United Kingdom), R. Quadery (Sheffield, United Kingdom), D. G Kiely (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom), A. J Swift (Sheffield, United Kingdom)
Introduction of a national multidisciplinary CTEPH board to improve operability assessment I. Opitz (Zurich, Switzerland), F. Lador (Geneva, Switzerland), J. Aubert (Lausanne, Switzerland), M. Tamm (Basel, Switzerland), K. Furrer (Zurich, Switzerland), M. Lichtblau (Zurich, Switzerland), C. Berlier (Zurich, Switzerland), T. Frauenfelder (Zurich, Switzerland), T. Pfammatter (Zurich, Switzerland), A. Hachulla (Geneva, Switzerland), P. Yerly (Lausanne, Switzerland), J. Fellrath (Neuchâtel, Switzerland), S. Ulrich (Zurich, Switzerland)
Survival in patients with chronic thromboembolic pulmonary hypertension in the modern management era Y. Taniguchi (Kobe, Japan), Y. Matsuoka (Kobe, Japan), H. Onishi (Kobe, Japan), N. Emoto (Kobe, Japan), H. Nakai (Kobe, Japan), K. Okada (Kobe, Japan), K. Hirata (Kobe, Japan)
Epidemiology of chronic thromboembolic pulmonary hypertension (CTEPH) in the Czech Republic P. Jansa (Prague, Czech Republic), D. Ambrož (Prague, Czech Republic), M. Kuhn (Brno, Czech Republic), V. Dytrych (Prague, Czech Republic), A. Linhart (Prague, Czech Republic), J. Lindner (Prague, Czech Republic), A. Muller (Allschwil, Switzerland)
Adherence to guidelines of anticoagulant prescription in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: an observational study R. Rainone (LE KREMLIN-BICETRE, France), B. Querin (LE KREMLIN-BICETRE, France), N. Alioua (LE KREMLIN-BICETRE, France), L. Bertoletti (SAINT-ETIENNE, France), S. Raspaud (LE KREMLIN-BICETRE, France), X. Jaïs (LE KREMLIN-BICETRE, France), L. Savale (LE KREMLIN-BICETRE, France), O. Sitbon (LE KREMLIN-BICETRE, France), M. Humbert (LE KREMLIN-BICETRE, France), D. Montani (LE KREMLIN-BICETRE, France), M. Chaumais (LE KREMLIN-BICETRE, France)
Supervised exercise training in patients with chronic thromboembolic pulmonary hypertension (CTEPH) as early follow-up treatment after pulmonary endarterectomy (PEA) – a prospective cohort study C. Nagel (Baden Baden, Germany), M. Nasereddin (Heidelberg, Germany), N. Benjamin (Heidelberg, Germany), B. Egenlauf (Heidelberg, Germany), S. Harutyunova (Heidelberg, Germany), C. Eichstaedt (Heidelberg, Germany), P. Xanthouli (Heidelberg, Germany), E. Mayer (Bad Nauheim, Germany), E. Grünig (Heidelberg, Germany), S. Guth (Bad Nauheim, Germany)
Pulmonary angioplasty vs exclusive medical treatment in inoperable chronic thromboembolic hypertension–initial outcomes from a pulmonary hypertension centre I. Furtado (Porto, Portugal), D. Silva (Viana do Castelo, Portugal), L. Carvalho (Porto, Portugal), M. Santos (Porto, Portugal), F. Gonçalves (Porto, Portugal), A. Luz (Porto, Portugal), A. Reis (Porto, Portugal)
BPA for CTEPH: the Viennese experience C. Gerges (Wien, Austria), R. Friewald (Wien, Austria), I. Shafran (Wien, Austria), R. Sadushi-Kolici (Wien, Austria), N. Skoro-Sajer (Wien, Austria), M. Gerges (Wien, Austria), B. Moser (Wien, Austria), S. Taghavi (Wien, Austria), W. Klepetko (Wien, Austria), I. Lang (Wien, Austria)
Predictive Value of CT Pulmonary Angiography (CTPA) to Assess the Surgical Accessibility for Pulmonary Endarterectomy in Patients with CTEPH T. Frauenfelder (Zurich, Switzerland), M. Mcinnis (Toronto, Canada), M. Eberhard (Zurich, Switzerland), M. De Perrot (Toronto, Canada), S. Ulrich (Zurich, Switzerland), I. Inci (Zurich, Switzerland), I. Opitz (Zurich, Switzerland)
LSC - 2020 - Comparison of metabolic profile in endothelial cells of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension O. Tura-Ceide (Barcelona, Spain)
Transforming growth factor beta induces Beclin-1 in pulmonary arterial endothelial cells P. CHEN (Tao-Yuan, Taiwan), Y. Lai (Tao-Yuan, Taiwan)
Elevated Von Willebrand Factor expression in the activated pulmonary endothelium of chronic thromboembolic pulmonary hypertension patients enhances platelet adhesion. X. Manz (Amsterdam, Netherlands), X. Pan (Amsterdam, Netherlands), P. Symersky (Amsterdam, Netherlands), J. Majolée (Amsterdam, Netherlands), P. Hordijk (Amsterdam, Netherlands), J. Voorberg (Amsterdam, Netherlands), J. Aman (Amsterdam, Netherlands), H. Bogaard (Amsterdam, Netherlands), R. Szulcek (Amsterdam, Netherlands)
Plasma metabolomics in chronic thromboembolic pulmonary hypertension E. Swietlik (Cambridge, United Kingdom), P. Ghataorhe (London, United Kingdom), K. Zalewska (Cardiff, United Kingdom), J. Wharton (London, United Kingdom), L. Howard (London, United Kingdom), D. Taboada (Cambridge, United Kingdom), J. Cannon (Cambridge, United Kingdom), N. Morrell (Cambridge, United Kingdom), M. Wilkins (London, United Kingdom), M. Toshner (Cambridge, United Kingdom), J. Pepke-Zaba (Cambridge, United Kingdom), C. Rhodes (London, United Kingdom)
MicroRNA expression analysis in Chronic Thromboembolic Pulmonary Hypertension using pulmonary endarterectomy derived samples I. Martínez López (Zurich, Switzerland), T. Papasotiropoulos (Zurich, Switzerland), F. Schlaepfer (Zurich, Switzerland), S. Ulrich (Zurich, Switzerland), M. Kirschner (Zurich, Switzerland), I. Opitz (Zurich, Switzerland)